Shared care guidelines
- gastro-intestinal system
- cardiovascular system
- respiratory system
- central nervous system
- infections
- endocrine system
- obstetrics, gynaecology and urinary-tract disorders
- malignant disease and immunosuppression
- nutrition and blood
- musculoskeletal joint diseases
- eye
- ear, nose and oropharynx
- skin
- immunological products and vaccines
- anaesthesia
Gastro-intestinal system
Cardiovascular system
Respiratory system
Guidelines currently unavailable. They will be added here when released.
Central nervous system
- atypical antipsychotics for schizophrenia
- risperidone in children
- lithium
- methylphenidate in children
- methylphenidate in adults
- atomoxetine in children
- atomoxetine in adults
- dexamfetamine
- tapentadol
- memantine
- midazolam
- midazolam for paediatric patients
- amantadine
- dopamine agonists
- entacapone
- selegiline
- riluzole
- acamprosate
- naltrexone
- acetylcholinesterase inhibitors
Infections
Endocrine system
- exenatide, including m/r and liraglutide
- denosumab for the prevention of fragility fractures
- denosumab for the prevention of skeletal-related events
Obstetrics, gynaecology and urinary-tract disorders
Guidelines currently unavailable. They will be added here when released.
Malignant disease and immunosuppression
Nutrition and blood
Musculoskeletal joint diseases
Eye
Guidelines currently unavailable. They will be added here when released.
Ear, nose and oropharynx
Guidelines currently unavailable. They will be added here when released.
Skin
Immunological products and vaccines
Guidelines currently unavailable. They will be added here when released.
Anaesthesia
Guidelines currently unavailable. They will be added here when released.
